Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome P450 family 4 subfamily F member 25, pseudogene (CYP4F25P), is a **pseudogene** belonging to the cytochrome P450 superfamily, specifically the 4F subfamily. As a pseudogene, it contains DNA sequence similar to protein-coding genes in the P450 family but carries mutations or deletions that prevent it from encoding a functional enzyme. Pseudogenes like CYP4F25P are generally considered non-functional at the protein level; they do not act as therapeutic targets (such as receptors, enzymes, transporters) and have no established role in drug interactions or human disease. While the cytochrome P450 family is critical for the metabolism of drugs and endogenous compounds, CYP4F25P itself does not encode an active protein and is not clinically actionable[1][3][5][7][9]. **Note:** This entry is not suitable as a therapeutic or pharmacological target due to its status as a pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome P450 family 4 subfamily F member 25, pseudogene (CYP4F25P).